#VisualAbstract: Tenecteplase is Non-Inferior to Alteplase for Acute Ischemic Stroke within 4.5 Hours of Onset
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Tag: tenecteplase
Delayed tenecteplase use improves recovery in ischemic stroke
1. In this randomized controlled trial, among patients with ischemic stroke without access to thrombectomy, tenecteplase given between 4.5 and ...
Intravenous tenecteplase shows no benefit in minor ischaemic stroke with intracranial occlusion
1. Return to baseline function was comparable in tenecteplase and standard-of-care groups. 2. More deaths and intracranial hemorrhages were reported ...
Tenecteplase is equivalent to placebo between 4.5 and 24 hours after stroke onset
1. In this randomized controlled trial, tenecteplase administered at 4.5 to 24 hours after stroke onset to patients with an ...
#VisualAbstract: Tenecteplase therapy initiated within 4.5 to 24 hours after stroke symptom onset is non-superior to placebo
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
Intravenous thrombolysis plus endovascular treatment may be more efficacious for acute ischemic stroke
1. The 90-day modified Ranking Scale score was comparable for patients in intravenous thrombolysis plus endovascular treatment versus endovascular treatment ...
Intravenous tenecteplase non-inferior to alteplase for patients with acute ischemic strokes
1. A similar proportion of patients in the alteplase group reported a modified Rankin Scale score of 0-1 compared to ...
Intravenous tenecteplase non-inferior to alteplase for thrombolysis in acute ischemic stroke
1. IV tenecteplase was non-inferior to IV alteplase for treatment of acute ischemic stroke regarding the primary outcome of a ...
Bridging therapy is superior to direct thrombectomy within 4.5 hours of acute ischemic stroke
1. Fewer patients in the direct thrombectomy achieved functional independence at 90 days compared to the bridging therapy group. 2. ...